Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
58 studies found for:    NIAID | Open Studies | healthy
Show Display Options
Rank Status Study
21 Recruiting Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women
Conditions: Microbiome;   Antibiotic-Induced VVC;   Vaginal Candidiasis
Intervention:
22 Recruiting Multiple Ascending Dose Study of Oxfendazole in Healthy Adult Volunteers
Condition: Helminthic Infection
Intervention: Drug: Oxfendazole
23 Recruiting Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
Condition: Influenza
Intervention: Biological: Influenza Virus Vaccine Inactivated
24 Not yet recruiting MVA-BN®-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers
Conditions: Ebola Disease;   Marburg Disease
Interventions: Biological: Ad26 Zaire Ebola Vaccine;   Biological: MVA Multi-Filo Ebola Vaccine
25 Recruiting Phase 1 Study of dmLT ID Vaccination in Healthy Adults
Condition: Gastroenteritis Escherichia Coli
Interventions: Other: Placebo;   Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine
26 Recruiting PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States
Condition: Plasmodium Falciparum Infection
Interventions: Drug: Chloroquine;   Biological: PfSPZ;   Other: Placebo
27 Not yet recruiting Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®-or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV (vCP2438);   Biological: Bivalent subtype C gp120/MF59;   Biological: Bivalent subtype C gp120/AS01(B);   Biological: Placebo
28 Recruiting Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: VRC01LS
29 Recruiting Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: Bivalent Subtype C gp120/MF59 vaccine;   Biological: Bivalent Subtype C gp120/AS01B vaccine;   Biological: Placebo
30 Recruiting A Phase I Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
Condition: Yellow Fever
Interventions: Drug: ISA-720;   Biological: MVA Smallpox Vaccine;   Biological: MVA-BN Yellow Fever Vaccine;   Other: Placebo;   Biological: YF Vax 17D Strain
31 Recruiting Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205
Condition: HIV Infections
Interventions: Biological: MVA/HIV62B vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo
32 Recruiting A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.
Condition: Zika Virus Infection
Interventions: Biological: IXIARO;   Biological: YF Vax 17D Strain;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
33 Recruiting Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Conditions: Healthy Participants;   Rheumatoid Arthritis (RA) Prevention
Interventions: Drug: Hydroxychloroquine;   Drug: HCQ Placebo
34 Recruiting Tissue Biopsy and Imaging Studies in HIV-Infected Patients
Conditions: HIV;   Healthy Volunteers
Intervention:
35 Recruiting Evaluation and Follow-up of Patients With Cryptococcosis
Condition: Cryptococcosis
Intervention:
36 Recruiting VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers
Condition: Bacterial Infections
Interventions: Drug: VNRX-5133;   Drug: Placebo
37 Recruiting Genetic and Environmental Factors in the Response to Influenza Vaccination
Conditions: Influenza;   Healthy
Interventions: Biological: FluMist® Quadrivalent;   Biological: Fluzone® Quadrivalent vaccine
38 Recruiting A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.
Condition: HIV Infections
Intervention: Biological: rAAV1-PG9DP
39 Recruiting Safety and Immune Response to a Clade C DNA HIV Vaccine
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: Protein/MF59 vaccine;   Biological: Placebo
40 Not yet recruiting Phase I Trial of Measles Vectored Chikungungya Vaccine
Condition: Chikungunya Virus Infection
Interventions: Biological: Chikungunya vaccine;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-58) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.